Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Massachusetts for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Massachusetts only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Massachusetts (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Salvatore Napoli (NPI 1588715882)

Field	Value
Entity Type	Individual
Organization	Salvatore Napoli
Address	18 Washington St
City	Foxboro
State	MA
ZIP	02035
Taxonomy	Neurology Physician
NPI Enumerated	January 15, 2007

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

This provider is effectively single-payer: total Medicare revenue is $2.3M and there is no Medicaid billing on file. The NPI was enumerated 2007-01-15 (~19 years ago), indicating a long-tenured Medicare billing history concentrated entirely in the Medicare program. This tenure plus the single-payer footprint suggests operational focus on Medicare populations rather than dual Medicaid/Medicare practice patterns.

Revenue is highly concentrated in a small set of biologic injectable codes: the precomputed top‑3 Medicare codes account for 85.2% of this provider’s total Medicare revenue. J2350 alone generates $1.3M (57.3% of Medicare revenue), while J2323 contributes $346.7K (14.8%) and J3245 contributes $308.4K (13.2%). This concentration implies material dependence on a few high‑revenue injectable products and the business risk that changes in reimbursement, utilization, or product access for those agents would materially affect the provider’s Medicare revenue.

The code mix points to an infusion/injection‑centric neurology practice model. The top revenue drivers are injectable biologics (J2350, J2323, J3245) consistent with ongoing administration of high‑cost specialty therapies, and the presence of infusion and chemotherapy administration codes such as 96413, 96365, 96415 and 96366 indicates on‑site capacity to deliver IV/infusion therapies beyond simple office visits. Together these patterns are consistent with a practice organized around recurring infusion/injection visits and associated clinical monitoring rather than a purely consultative, visit‑only neurology practice.

Competitive standing on the largest single code is notable: J2350 ranks #9 of 105 providers nationally (92th percentile), which places the provider among the higher national performers for that specific code even though the dataset labels the volume as "typical, unremarkable" for the code. By contrast, J2323 (19.3K claims, $346.7K revenue) ranks #21 of 40 (49th percentile) and J3245 (2.8K claims, $308.4K revenue) ranks #151 of 225 (33th percentile); both are described in the source as "typical, unremarkable" volumes, indicating that outside J2350 the provider’s footprint on other biologics is more modest.

Evaluation-and-management billing shows a mixture of high-acuity visits and a small share of total revenue: 99215 accounts for $50.3K (2.1% of Medicare revenue) and is labeled "notably above typical national volume for this code" (rank #4006 of 145531, 97th percentile). Lower‑level E&M codes (99214, 99213) appear with smaller revenue shares. This pattern suggests the practice bills a meaningful number of higher‑complexity follow‑up encounters in addition to infusion services, which may reflect ongoing clinical management needs of complex chronic conditions.

The provider demonstrates adoption of remote care and monitoring services at a modest revenue level: codes 99457 and 99454 appear in the top codes (combined revenue under $14K) and rank around midpercentiles nationally. While these services are not large revenue contributors, their presence indicates implementation of remote physiologic monitoring and digital care management workflows that complement the infusion/injection service line.

There are a few statistical high‑volume signals on otherwise low‑revenue codes that deserve attention: J2930 (307 claims, $1.2K revenue) is labeled "notably above typical national volume for this code" (97th percentile), and several infusion add‑on and administration codes (96415, 96375, 96366) sit at elevated percentiles for their categories despite small dollar impact. These outlier labels suggest the provider’s operational profile emphasizes procedural throughput (injections/infusions) even when those lines do not individually drive large revenue dollars beyond the dominant biologic codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	33,600	$40	$1.3M
J2323	Injection, natalizumab, 1 mg	19,260	$20	$346.7K
J3245	Injection, tildrakizumab, 1 mg	2,800	$110	$308.4K
J0585	Injection, onabotulinumtoxina, 1 unit	23,620	$10	$118.1K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	360	$140	$50.3K
J3032	Injection, eptinezumab-jjmr, 1 mg	3,310	$10	$43.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	360	$100	$35.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	300	$120	$34.2K
64615	The provider bilaterally administers a chemical compound to the muscles innervated by the trigeminal, facial, cervical spinal, and accessory nerves. The goal of this procedure is to paralyze the…	140	$130	$18.2K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	160	$60	$8.9K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Massachusetts Distribution

Salvatore Napoli — 2 of 23 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Massachusetts

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	2	10	33,600	$40	$1.2M
J3245	3	10	9,400	$110	$799.8K
J2323	1	10	19,260	$20	$344.4K
J0585	14	100	6,500	$1	$60.7K
J3032	1	10	3,310	$10	$44.6K
96413	10	60	120	$110	$17.6K
99214	2,181	15,410	110	$80	$15.6K
99490	208	230	180	$50	$12.8K
99215	122	6,360	40	$120	$8.9K
99213	9,458	13,700	70	$60	$8.8K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Salvatore Napoli, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Anthony Rodrigues	MA	Neurology with Special Qualifications in Child Neurology Physician	$137.9K	$122.5K
Andrew Taylor	MA	Neurology Physician	$91.6K	$0
Preeti Gupta	RI	Neurology Physician	$70.4K	$0
Carolyn Metivier	MA	Nurse Practitioner	$32.7K	$0

Nearby Providers

Other providers in the same ZIP code as Salvatore Napoli, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bayada Home Health Care, Inc.	MA	Home Health Agency	$0	$39.5M
Peace & Harmony Home Care LLC	MA	Home Health Agency	$0	$10.9M
Adult Day Health, Inc.	MA	Adult Day Care Clinic/Center	$0	$8.8M
Town Of Foxborough	MA	Land Ambulance	$337.5K	$746.6K
Charles Wolff	MA	Family Medicine Physician	$232.9K	$10.5K
Emily Robinson	MA	Nephrology Physician	$211.3K	$0
Austin Meeker	MA	Ophthalmology Physician	$166.5K	$0
Jennifer Kurz	MA	Pain Medicine (Physical Medicine & Rehabilitation) Physician	$113.9K	$0
Lauren De Leon	MA	Internal Medicine Physician	$71.4K	$150
Nelofer Humayon	MA	Internal Medicine Physician	$15.9K	$0

Salvatore Napoli — Billing Profile & Reimbursement Data

Sign up for Salvatore Napoli — Billing Profile & Reimbursement Data policy alerts

Salvatore Napoli — Billing Profile & Reimbursement Data

Sign up for Salvatore Napoli — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References